Feb 17, 2015 at 12:19 | Source: Moneycontrol.com
Elder Projects has reported a standalone total income from operations of Rs 1.02 crore and a net loss of Rs 0.36 crore for the quarter ended Dec '14
Feb 17, 2015 at 11:09 | Source: Moneycontrol.com
Elder Pharmaceuticals has reported a consolidated total income from operations of Rs 157.93 crore and a net loss of Rs 83.56 crore for the quarter ended Dec '14
Feb 14, 2015 at 13:55 | Source: Moneycontrol.com
Elder Healthcare has reported a standalone total income from operations of Rs 1.68 crore and a net loss of Rs 2.61 crore for the quarter ended Dec '14
Jan 12, 2015 at 12:12 | Source: CNBC-TV18
Samir Mehta of Torrent Pharma says integration with Elder Pharma has worked out well and will become cash-accretive by next year.
Jan 09, 2015 at 11:26 | Source: Moneycontrol.com
Pharma stocks like Dr Reddy's Labs, Cipla, Glenmark, Biocon, Divis Lab, Elder Pharma will be getting astrological support, says Satish Gupta of Astrostocktips.
Jan 08, 2015 at 15:32 | Source: CNBC-TV18
Sharmila Joshi of sharmilajoshi.com recommends buying ICICI Bank and Kotak Mahindra Bank.
Jan 05, 2015 at 12:42 | Source: CNBC-TV18
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have Ashok Leyland, Persistent Systems, BL Kashyap, MOIL, VA Tech, Elder Pharma, TCI and Bharti Airtel.
Jan 05, 2015 at 08:35 | Source: CNBC-TV18
IDBI Bank | Central Bank of India | Elder Pharma | NTPC | NHPC | Coal India | IOC | SpiceJet | Ashok Leyland | Fedders Lloyd and Ashiana Housing are stocks, which are in the news today.
Jan 01, 2015 at 10:46 | Source: Moneycontrol.com
Pharma stocks like Wockhardt, Glenmark Pharma, Elder Pharma, JB Chemical, Dishman Pharma etc will be getting astrological support, says Satish Gupta of Astrostocktips.
Dec 24, 2014 at 15:07 | Source: Moneycontrol.com
The brokerage feels earnings momentum for Torrent is set to accelerate over the next two years led by an improving product mix and scale benefits in key markets of India and Brazil. Strong positioning in these markets which have high growth visibility and robust core earnings growth of 25 percent will support current valuations, says the report.